Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine

BACKGROUND: Injection-site reactions have been reported with biologicals. In this post hoc analysis of Phase 3 studies in participants with migraine, we provide a comprehensive overview and detailed summary of injection-site reaction with galcanezumab. METHODS: Data were obtained from two randomised...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Neurol
Egile Nagusiak: Stauffer, Virginia L., Wang, Shufang, Bonner, Jo, Kim, ByungKun, Bhandari, Rohit, Day, Kathleen A., Camporeale, Angelo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7236916/
https://ncbi.nlm.nih.gov/pubmed/32429851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-020-01775-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak